CIRBP and breast carcinoma: An integrated analysis of serum autoantibody expression profiling in patients with breast cancer, found that serum autoantibody targeting CIRP was significantly increased in patients with breast carcinoma and its change can be used as a prognostic biomarker for cancer progression [75].